Sign inJoin waitlistJoin the waitlist

Aravindhan Veerapandiyan

Associate Professor of Pediatrics · University of Arkansas for Medical Sciences (UAMS) College of Medicine

Credentials: · ·

History

Rutgers University
2018–2019
Neuromuscular Medicine
University of Rochester Medicine
2017–2018
Child Neurology
Rutgers Health
2014–2017
Rutgers New Jersey Medical School
2013–2014
Duke University Hospital
2012–2013
K A P VISHWANATHAN GOVERNMENT MEDICAL COLLEGE
2003–2007

Research

AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial
Nature Medicine · 2025 · 143 citations
Subacute Liver Failure Following Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
Case report · The Journal of Pediatrics · 2020 · 110 citations
Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions
Journal of Intellectual Disability Research · 2012 · 69 citations

Craig McDonald
9 papers
CP
Crystal Proud
9 papers
Emma Ciafaloni
9 papers
Russell Butterfield
8 papers
Ruthwik Duvuru
8 papers · 3 as a resident
SM
Sue Ming
8 papers
Vikki Stefans
8 papers
Jonathan Soslow
7 papers
Mohamad Mikati
7 papers
Susan Apkon
7 papers
Craig Zaidman
6 papers
Cuixia Tian
6 papers

Clinical trials

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
Site PI · Recruiting · Phase 1, Phase 2
Precision BioSciences, Inc.
2026–2029
A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Site PI · Recruiting
ITF Therapeutics LLC
2025–2030
Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
Site PI · Recruiting
Virginia Commonwealth University
2025–2030
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Site PI · Recruiting · Phase 1, Phase 2
Solid Biosciences Inc.
2024–2031